Marcus Conant | Academic Influence

Marcus Conant's AcademicInfluence.com Rankings

Marcus Conant

Philosophy

#10952

World Rank

#15035

Historical Rank

#2054

USA Rank

Logic

#7954

World Rank

#9896

Historical Rank

#1266

USA Rank

philosophy Degrees

Download Badge

Philosophy

Marcus Conant's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Marcus Conant Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Marcus Augustine Conant is an American dermatologist and one of the first physicians to diagnose and treat Acquired Immune Deficiency Syndrome in 1981. He helped create one of the largest private AIDS clinics, was a founder of the San Francisco AIDS Foundation, and his work contributed to development of some of today's top HIV medications. He has written over 70 publications on the treatment of AIDS.

(See a Problem?)

Marcus Conant's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. (1985) (795)
A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs (1998) (405)
ORAL "HAIRY" LEUCOPLAKIA IN MALE HOMOSEXUALS: EVIDENCE OF ASSOCIATION WITH BOTH PAPILLOMAVIRUS AND A HERPES-GROUP VIRUS (1984) (402)
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. (1984) (291)
Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. (1993) (286)
B-cell immunodeficiency in acquired immune deficiency syndrome. (1984) (274)
Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. (1986) (266)
CYTOMEGALOVIRUS AND KAPOSI'S SARCOMA IN YOUNG HOMOSEXUAL MEN (1982) (236)
Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. (1987) (236)
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy (2002) (217)
Natural interferon alfa for treatment of condylomata acuminata. (1988) (182)
Acquired immune dysfunction in homosexual men: immunologic profiles. (1983) (170)
Condoms prevent transmission of AIDS-associated retrovirus. (1986) (168)
Reported changes in the sexual behavior of men at risk for AIDS, San Francisco, 1982-84--the AIDS Behavioral Research Project. (1985) (159)
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection. (1998) (152)
Psychological and immunological predictors of genital herpes recurrence. (1989) (141)
Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. (1983) (134)
Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. (1985) (130)
Evaluation of the virus permeability of a new condom for women. (1990) (125)
Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. (1983) (123)
PATIENT-APPLIED PODOFILOX FOR TREATMENT OF GENITAL WARTS (1989) (123)
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials (2002) (120)
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients (2007) (114)
Long-term Suppression of Recurrent Genital Herpes With Acyclovir: A 5-Year Benchmark (1993) (106)
Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. (1999) (101)
Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? (1990) (93)
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group. (1999) (88)
Herpes zoster ophthalmicus and acquired immune deficiency syndrome. (1984) (85)
Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. (1996) (85)
Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir. (1997) (80)
Hematologic manifestations in homosexual men with Kaposi's sarcoma. (1984) (78)
Persistent stress as a predictor of genital herpes recurrence. (1999) (78)
Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group. (1993) (74)
Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. (2006) (73)
Kaposi's sarcoma in homosexual men: an immunohistochemical study. (1983) (69)
Anonymous HIV testing using home collection and telemedicine counseling. A multicenter evaluation. (1997) (67)
Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (1996) (66)
Imiquimod; an international update on therapeutic uses in dermatology (2002) (65)
Zidovudine improves psoriasis in human immunodeficiency virus-positive males. (1994) (62)
Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. (1989) (61)
Multiple glomus tumors of the skin. (1971) (61)
T-lymphocyte subsets in lymph nodes from homosexual men. (1983) (60)
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511) (2001) (60)
New outbreak of oral tumors, malignancies and infectious diseases strikes young male homosexuals. (1982) (58)
Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia. (1990) (56)
Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis. (1995) (55)
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection. (1988) (53)
Targeting AIDS prevention and treatment toward HIV-1-infected persons. The concept of early intervention. (1989) (53)
Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study (2002) (48)
ALTERED DISTRIBUTION OF B AND T LYMPHOCYTES IN LYMPH-NODES FROM HOMOSEXUAL MEN WITH KAPOSI'S SARCOMA (1983) (42)
Chemotherapy in advanced Kaposi's sarcoma. Implications for current cases in homosexual men. (1983) (39)
Lamellar ichthyosis of the newborn. A distinct clinical entity: its comparison to the other ichthyosiform erythrodermas. (1972) (39)
Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety. (1986) (39)
The AIDS epidemic: a model for developing intervention strategies for reducing high-risk behavior in gay men. (1985) (39)
Immunomodulatory therapy in the management of viral infections in patients with HIV infection. (2000) (37)
Neuralgia in recurrent herpes simplex. (1974) (34)
Molluscum contagiosum: normal and virus infected epidermal cell kinetics. (1966) (33)
Perioral leukoderma simulating vitiligo from use of a toothpaste containing cinnamic aldehyde. (1980) (33)
SQUAMOUS CELL CARCINOMA IN SEXUAL PARTNER OF KAPOSI SARCOMA PATIENT (1982) (32)
Condoms prevent transmission of AIDS-associated retrovirus [letter] (1986) (31)
Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies (2006) (27)
Basement membrane and connective tissue proteins in early lesions of Kaposi's sarcoma associated with AIDS. (1985) (27)
Hairy leukoplakia. A new disease of the oral mucosa. (1987) (24)
The AIDS epidemic. (1994) (23)
Delayed hypersensitivity to retrobulbar injections of methylprednisolone acetate. (1978) (23)
The diagnosis of AIDS and AIDS related complex in the dental office: findings in 171 homosexual males. (1984) (22)
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis. (1992) (21)
Lyell's disease, the Stevens-Johnson Syndrome, and exfoliative dermatitis. (1970) (20)
Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES) (2012) (20)
Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences. (1989) (20)
Prophylactic and suppressive treatment with acyclovir and the management of herpes in patients with acquired immunodeficiency syndrome. (1988) (19)
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study. (2001) (19)
AIDS IN THE "GAY" AREAS OF SAN FRANCISCO (1983) (17)
Fungal infections in immunocompromised individuals. (1996) (17)
Incidence of the acquired immunodeficiency syndrome in San Francisco, 1980-1983. (1985) (16)
Mucocutaneous candidiasis or mucocutaneous microbiosis? (1978) (13)
Comparison of Uniphyl tablets and inhaled albuterol as maintenance therapy in asthmatic adults (1988) (12)
Oral viral leukoplakia--a new AIDS-associated condition. (1985) (11)
Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex (1987) (10)
Speculations on the viral etiology of acquired immune deficiency syndrome and Kaposi's sarcoma. (1984) (9)
Management of human immunodeficiency virus-associated malignancies. (1995) (9)
Perforation of the colon in high-dose corticosteroid therapy of pemphigus. (1982) (7)
Genital herpes: an integrated approach to management. (1996) (6)
Participation of health care personnel in torture and interrogation. (2005) (6)
Allergic Contact Dermatitis Due to Neutral Red (1974) (6)
Episodic twice-daily treatment for recurrent genital herpes. (1988) (6)
From HIV Infection to AIDS: Changes in the Microbial Ecology of Skin and Nose (1991) (6)
AIDS: a new disease. (1985) (6)
Losing the war on AIDS. (2004) (5)
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. (1995) (5)
Imiquimod and genital herpes. (2002) (5)
Incidence of the acquired immunodeficiency syndrome in San Francisco. (1985) (4)
Severe Opportunistic Infections In AIDS Patients With Late-Stage Disease (1994) (4)
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens (2019) (4)
The Facial Appearance Inventory: Development and Preliminary Evidence for Reliability and Validity in People with HIV and Lipoatrophy. (2016) (4)
The UCSF AIDS Specimen Bank (1991) (4)
AIDS and Kaposi's sarcoma. (1985) (4)
Participation in Torture and Interrogation: An Inexcusable Breach of Medical Ethics—A Call to Hold Military Medical Personnel Accountable to Accepted Professional Standards (2006) (4)
Therapeutics. Patients-applied podofilox for treatment of genital warts (1989) (3)
Dermatology's role in sexually transmitted diseases. (1986) (2)
Proceedings of the 33rd annual symposium on the biology of skin cutaneous oncogenic viruses. (1984) (2)
Letter: Allergic contact dermatitis due to neutral red. (1974) (2)
Modified Goeckerman Regimen: Decreased Treatment Time (1976) (2)
Current clinical issues in the management of herpes simplex virus infections in patients with HIV. (1997) (2)
AIDS: A Global Epidemic (1988) (1)
Current assessment; dental risks and guidelines in the AIDS epidemic. (1983) (1)
Secondary syphilis misdiagnosed as infectious mononucleosis. (1968) (1)
HIV disease prevention and treatment. A model for local planning. (1988) (1)
AIDS: prevention strategies. (1985) (1)
Disseminated Kaposi's sarcoma in male homosexuals. (1983) (1)
Introduction and welcome (1988) (1)
Condoms and the Prevention of AIDS-Reply (1986) (1)
HIV related skin diseases clear with combination therapy. (1998) (1)
AIDS vaccine trial volunteers can be found. (1987) (1)
Letter: Modified Goeckerman regimen: decreased treatment time. (1976) (0)
Society Transactions San Francisco Dermatological Society January 15, 1982 (1982) (0)
Proceedings: Bloom syndrome. (1974) (0)
IMPORTANT ADVANCES IN CLINICAL MEDICINE: DERMATOLOGY (1998) (0)
The Role of Clostridium Botulinum: A (2005) (0)
Hematologic Manifestations in Homosexual Men With Kaposi’s Sarcoma (1984) (0)
Letter from Marcus A. Conant, University of California, San Francisco to Harold Varmus (1985) (0)
Diseases of the Oral Mucosa (1980) (0)
The AIDS epidemic, then and now. (2013) (0)
Lessons from the AIDS Epidemic (1997) (0)
Worcester, Barre and Cheshire R.R. route to Winchendon, Massachusetts / M. Conant, engr. (2011) (0)
Titer affinity parameter a new blood marker for monitoring individuals with hiv disease (1990) (0)
The Current Face of the AIDS Epidemic (1997) (0)
AIDS: the modern day plague (1995) (0)
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James. (1995) (0)
Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or Hydroxyurea 1571 (1985) (0)
Supreme Court Ruling Stirs the Pot (2005) (0)
AIDS in the workplace. A new dilemma. (1986) (0)
Future issues in AIDS. (1991) (0)
Holmes and Motulsky, eds. AIDS: A guide for the primary physician. Seattle: University of Washington Press, 1988. 66 pp. $15.00. paper (1989) (0)
New treatment options for onychomycosis. (1995) (0)
Human immunodeficiency virus: current status (1995) (0)

This paper list is powered by the following services:

Other Resources About Marcus Conant

en.wikipedia.org

What Schools Are Affiliated With Marcus Conant?

Marcus Conant is affiliated with the following schools:

University of California, San Francisco